Dillon’s Law
Dillon’s Law incentivizes states to allow any trained individual to administer epinephrine in schools during emergencies.
Allergists reimbursement challenges
Last month saw the publication of two highly anticipated annual reports that analyze the state of the Medicare program.
House committee hearing signals scrutiny ahead for Medicare Advantage
Lawmakers on both sides of the aisle expressed frustration with the current state of the Medicare Advantage (MA) program.
One class action is settled – and one you may want to join
You may be eligible to recover compensation for suppressed reimbursement rates. However, you must file a claim. The deadline is July 29, 2025
How will new prior authorization announcements impact allergists?
Recently there were two major announcements from commercial and government payers about changes to how insurers use prior authorization.
Congress passes One Big Beautiful Bill Act
The bill is the product of many compromises and negotiations between the House and Senate and includes most of the Republican legislative agenda.
Checking in with the Advocacy Council
Since June is the midpoint of the year, it is the perfect time to share the various issues we’ve been working on to advocate for you.
Senate budget reconciliation text released
The Senate continues to work toward its goal of finalizing its version of the budget reconciliation bill by July 4.
The College has an advocate in Washington
Dr. Onder is an important voice for allergy. He is an advocate for our specialty, our patients, and our practices.
A review of the Make America Healthy Again report on childhood chronic diseases
While estimates vary depending on the specific condition, all available data point to a consistent, steady rise in chronic illnesses over time.
… results in Advocacy Insider.
